6533b82bfe1ef96bd128d6d5
RESEARCH PRODUCT
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study
Federica CosentinoVittoria MoscattAndrea MarinoAlessio PampaloniDaniele ScuderiManuela CeccarelliFrancesco BenantiMaria GussioLicia LaroccaVincenzo BosciaGiovanni VinciAldo ZagamiAnna OnoranteGaetano LupoSalvatore TorrisiSilvana GrassoRoberto BrunoCarmelo IacobelloSalvatore BonfanteLuigi GuarneriAntonio CascioAntonella FrancoRossella Del VecchioMaria Di RosoliniAlfredo PulvirentiDamiano LarnèGiuseppe NunnariBenedetto CelesiaBruno Cacopardosubject
predictors of death.SARS-CoV-2General Neurosciencepandemicepidemiological featuresGeneral MedicineGeneral Pharmacology Toxicology and Pharmaceuticsepidemiological featureSARS-CoV-2 pandemic epidemiological features predictors of deathpredictors of deathGeneral Biochemistry Genetics and Molecular Biologydescription
Since late December 2019, severe acute respiratory syndrome coronavirus 2 has spread across the world, which resulted in the World Health Organization declaring a global pandemic. Coronavirus disease 2019 (COVID-19) presents a highly variable spectrum with regard to the severity of illness. Most infected individuals exhibit a mild to moderate illness (81%); however, 14% have a serious disease and 5% develop severe acute respiratory distress syndrome (ARDS), requiring intensive care support. The mortality rate of COVID-19 continues to rise across the world. Data regarding predictors of mortality in patients with COVID 19 are still scarce but are being actively investigated. The present multicenter retrospective observational study provides a complete description of the demographic and clinical characteristics, comorbidities and laboratory abnormalities in a population of 421 hospitalized patients recruited across eight infectious disease units in Southern Italy (Sicily) with the aim of identifying the baseline characteristics predisposing COVID-19 patients to critical illness or death. In this study, older age, pre-existing comorbidities and certain changes in laboratory markers (such as neutrophilia, lymphocytopenia and increased C-reactive protein levels) at the time of admission were associated with a higher risk of mortality. Male sex, on the other hand, was not significantly associated with increased risk of mortality. Symptoms such as fatigue, older age, a number of co-pathologies and use of continuous positive airway pressure were the most significant contributors in the estimation of clinical prognosis. Further research is required to better characterize the epidemiological features of COVID-19, to understand the related predictors of death and to develop new effective therapeutic strategies.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2022-01-01 |